Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes fo...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

LodiDodiWeLikesToParty May. 13 at 5:04 AM

$CRIS More trials, it never ends. If it does work, we will never know because it will never hit the shelf. Big pharma doesn't want it to hit the shelf. Why doesn't cancer supersed covid, this has always been the number one killer.

0 · Reply

StocktwitsEarnings May. 12 at 9:59 PM

$CRIS Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.25 • Curis believes its $15M cash as of March 31, 2026, plus anticipated $20.2M from warrant exercise, should fund planned operations into the second half of 2027.

0 · Reply

EarningsInsider May. 12 at 9:17 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-curis-inc-stock/ $CRIS Curis Earnings Transcript

0 · Reply

TwongStocks May. 12 at 8:03 PM

$CRIS Curis Provides First Quarter 2026 Business Update https://www.prnewswire.com/news-releases/curis-provides-first-quarter-2026-business-update-302769980.html

0 · Reply

Unburdened May. 12 at 3:17 PM

$CRIS Earnings call after the close today I believe. Hoping for good news.

2 · Reply

CmonManGiveMeABreak May. 9 at 6:45 AM

$CRIS POS wen banrput

1 · Reply

jjangles123 May. 6 at 6:33 PM

$CRIS How are we feeling?

3 · Reply

focafoca99 May. 6 at 5:00 AM

$CRIS intends to report its first-quarter 2026 results and host a conference call on May 12.

0 · Reply

BallWasher69 May. 5 at 9:16 PM

$CRIS Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

0 · Reply

UCD_12dd May. 3 at 1:55 AM

$CRIS this was going to be my retirement stock six years ago. Oh well. Back to the drawing board

0 · Reply

Curis reports Q1 EPS ($1.25), consensus (29c)

2026-05-12T22:07:01.000Z - 18 hours ago

Curis sees cash and proceeds enough for operations into second half of FY27

May 12, 2026, 4:30 PM EDT - 19 hours ago

Curis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:00 PM EDT - 20 hours ago

Curis Provides First Quarter 2026 Business Update

May 5, 2026, 5:11 PM EDT - 7 days ago

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

Mar 19, 2026, 4:30 PM EDT - 7 weeks ago

Curis Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 7 weeks ago

Curis Provides Fourth Quarter 2025 Business Update

Mar 17, 2026, 11:00 AM EDT - 2 months ago

Curis Transcript: EGM 2026

Mar 12, 2026, 4:27 PM EDT - 2 months ago

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

Jan 9, 2026, 8:00 AM EST - 4 months ago

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Jan 7, 2026, 8:45 AM EST - 4 months ago

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Dec 9, 2025, 8:00 AM EST - 5 months ago

Curis Provides Updated Data from its Frontline AML Triplet Study

Nov 14, 2025, 9:26 AM EST - 6 months ago

Curis to Present at Upcoming 30th Annual SNO Meeting

Nov 6, 2025, 4:30 PM EST - 6 months ago

Curis Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:00 PM EST - 6 months ago

Curis Provides Third Quarter 2025 Business Update

Oct 30, 2025, 4:00 PM EDT - 6 months ago

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Oct 3, 2025, 4:00 PM EDT - 7 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 10, 2025, 10:00 AM EDT - 8 months ago

Curis Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 9:45 AM EDT - 8 months ago

Curis Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 10:43 AM EDT - 9 months ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 5, 2025, 8:30 AM EDT - 10 months ago

Curis Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 10 months ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 11 months ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 6, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 9, 2025, 4:30 PM EDT - 1 year ago

Curis Transcript: Jones Healthcare and Technology Innovation Conference 2025

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 28, 2025, 4:07 PM EDT - 1 year ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 10, 2024, 8:00 AM EST - 1 year ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 8:30 AM EST - 1 year ago

Curis Earnings Call Transcript: Q3 2024

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 1 year ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 1 year ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 3:05 PM EDT - 1 year ago

Curis Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 11, 2024, 1:00 PM EDT - 1 year ago

Curis Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Curis Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:00 AM EDT - 1 year ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conference in July

May 14, 2024, 4:30 PM EDT - 2 years ago

Curis Transcript: Status Update

May 10, 2024, 8:00 AM EDT - 2 years ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q1 2024

May 7, 2024, 8:00 AM EDT - 2 years ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 8, 2024, 12:45 PM EDT - 2 years ago

Curis Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 4, 2024, 7:30 AM EDT - 2 years ago

Curis to Present at Upcoming Healthcare Conferences in April

Feb 8, 2024, 8:30 AM EST - 2 years ago

Curis Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:00 AM EST - 2 years ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 1, 2024, 8:00 AM EST - 2 years ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 2 years ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 2 years ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 2 years ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Curis Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 2 years ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 2 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 3, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings Call Transcript: Q2 2023

Aug 3, 2023, 4:01 PM EDT - 3 years ago

Curis Provides Second Quarter 2023 Business Update

Jul 27, 2023, 6:25 PM EDT - 3 years ago

Curis to Release Second Quarter 2023 Financial Results and Hold Conference Call on August 3, 2023

Jul 6, 2023, 8:01 AM EDT - 3 years ago

FDA Removes Partial Clinical Hold on TakeAim Leukemia Study RP2D Established at 300 mg BID

Jul 6, 2023, 8:00 AM EDT - 3 years ago

Curis Announces $15.1 Million Registered Direct Offering

May 4, 2023, 4:30 PM EDT - 3 years ago

Curis Earnings Call Transcript: Q1 2023

May 4, 2023, 4:01 PM EDT - 3 years ago

Curis Provides First Quarter 2023 Business Update

Apr 27, 2023, 4:01 PM EDT - 3 years ago

Curis to Release First Quarter 2023 Financial Results and Hold Conference Call on May 4, 2023

LodiDodiWeLikesToParty May. 13 at 5:04 AM

0 · Reply

StocktwitsEarnings May. 12 at 9:59 PM

0 · Reply

EarningsInsider May. 12 at 9:17 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-curis-inc-stock/ $CRIS Curis Earnings Transcript

0 · Reply

TwongStocks May. 12 at 8:03 PM

$CRIS Curis Provides First Quarter 2026 Business Update https://www.prnewswire.com/news-releases/curis-provides-first-quarter-2026-business-update-302769980.html

0 · Reply

Unburdened May. 12 at 3:17 PM

$CRIS Earnings call after the close today I believe. Hoping for good news.

2 · Reply

CmonManGiveMeABreak May. 9 at 6:45 AM

$CRIS POS wen banrput

1 · Reply

jjangles123 May. 6 at 6:33 PM

$CRIS How are we feeling?

3 · Reply

focafoca99 May. 6 at 5:00 AM

$CRIS intends to report its first-quarter 2026 results and host a conference call on May 12.

0 · Reply

BallWasher69 May. 5 at 9:16 PM

$CRIS Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

0 · Reply

UCD_12dd May. 3 at 1:55 AM

$CRIS this was going to be my retirement stock six years ago. Oh well. Back to the drawing board

0 · Reply

BallWasher69 May. 1 at 8:25 PM

$CRIS wow - 8k just filed. Curis received a Nasdaq Delist Determination Letter on April 27, 2026. May 4, 2026: Deadline to request a hearing (appeal). May 6, 2026: Stock will be suspended and delisted if no appeal (or if unsuccessful). This may be 🪦🔜 Curis is under a “Discretionary Panel Monitor” This means no automatic grace period to fix the issue. Nasdaq can move straight to delisting (which it did).

3 · Reply

UCD_12dd Apr. 30 at 1:52 PM

$CRIS 7000 shares, all in.

2 · Reply

LodiDodiWeLikesToParty Apr. 30 at 1:32 PM

$CRIS So does this vote mean that are asking for approval on another r/s.

1 · Reply

BillionerOfKing Apr. 30 at 4:02 AM

$CRIS Current Stock Price: $0.56

0 · Reply

jjangles123 Apr. 28 at 12:44 PM

$CRIS Natanhala buying another 1million+ shares this past week

1 · Reply

JeffersonSovereign Apr. 27 at 3:45 PM

$CRIS s

0 · Reply

LodiDodiWeLikesToParty Apr. 21 at 10:30 PM

$CRIS probably looking at another reverse split. No revenue for this year and probably next year also. "FDA Fast tract," give me a break. These clowns have been vomiting that same rederic for several years.

0 · Reply

rombrento Apr. 21 at 7:51 PM

$CRIS

0 · Reply

BigBadBeethoven Apr. 17 at 8:34 PM

$CRIS "The company will have no meaningful revenue in 2026" And this is a TURNAROUND?

1 · Reply

BigBadBeethoven Apr. 17 at 8:29 PM

$CRIS DISAPPOINTING even with all the supposed turnaround news which is a very ODD turnaround switch because they're going to have no Revenue coming in this year LOL. Believe me, Don't buy this until after the reverse split.

0 · Reply

alexpitti Apr. 17 at 1:11 AM

$CRIS met the ceo today. maybe i caused it to fall lol

1 · Reply

UCD_12dd Apr. 16 at 9:40 PM

$CRIS what in the world happened in the last couple hours? There we go again!

0 · Reply

Market Cap	22.03M
Revenue (ttm)	9.44M
Net Income (ttm)	-7.58M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-80.30%
Debt to Equity Ratio	0.00

Volume	295,500
Avg Vol	472,926
Day's Range	N/A - N/A
Shares Out	39.98M
Stochastic %K	13%
Beta	3.08
Analysts	Strong Sell
Price Target	$11.00